Dientamoeba fragilis and chronic abdominal pain in children: A case-control study

Archives of Disease in Childhood: Education and Practice Edition

Volumn 99, Issue 12, 2014, Pages 1109-1113

  De Jong, Marin J ^a   Korterink, Judith J ^a   Benninga, Marc A ^b   Hilbink, Mirrian ^a   Widdershoven, J ^a,c   Deckers Kocken, Judith M ^a  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c Herlaarhof   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CLIOQUINOL; METRONIDAZOLE; PROTOZOAL DNA; ANTIPROTOZOAL AGENT;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ARTICLE; BACKACHE; BLOATING; CASE CONTROL STUDY; CHILD; CHILDHOOD DISEASE; CHRONIC PAIN; CONTROLLED STUDY; DIENTAMOEBA; DIENTAMOEBIASIS; DISEASE ASSOCIATION; EOSINOPHILIA; FATIGUE; FECES ANALYSIS; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PARASITE CLEARANCE; PARASITE LOAD; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SYMPTOMATOLOGY; CHRONIC DISEASE; FECES; GASTROINTESTINAL DISEASES; ISOLATION AND PURIFICATION; PARASITOLOGY; PREVALENCE; ANOREXIA; BLASTOCYSTOSIS; CLINICAL FEATURE; CONSTIPATION; DEFECATION DISORDER; DIARRHEA; ERUCTATION; FECES CULTURE; FEVER; FLATULENCE; INSOMNIA; LABORATORY TEST; MIXED INFECTION; MUCUS; MUSCLE CRAMP; OCCULT BLOOD; PHYSICAL EXAMINATION; VOMITING; WEIGHT REDUCTION;

ABDOMINAL PAIN; ADOLESCENT; ANTIPROTOZOAL AGENTS; CASE-CONTROL STUDIES; CHILD; CHRONIC DISEASE; CLIOQUINOL; DIENTAMOEBA; DIENTAMOEBIASIS; FECES; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; METRONIDAZOLE; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES;

EID: 84911002802     PISSN: 17430585     EISSN: 17430593     Source Type: Journal    
DOI: 10.1136/archdischild-2014-305942     Document Type: Article

References (37)

1. Chitkara DK, Rawat DJ, Talley NJ. The epidemiology of childhood recurrent abdominal pain in Western countries: a systematic review. Am J Gastroenterol 2005;100:1868-75.
2. Nurko S. The tip of the iceberg: the prevalence of functional gastrointestinal diseases in children. J Pediatr 2009;154:313-15.
3. Perquin CW, Hazebroek-Kampschreur AA, Hunfeld JA, et al. Chronic pain among children and adolescents: physician consultation and medication use. Clin J Pain 2000;16:229-35.
4. Saps M, Seshadri R, Sztainberg M, et al. A prospective school-based study of abdominal pain and other common somatic complaints in children. J Pediatr 2009;154:322-6.
5. Di Lorenzo C, Colletti RB, Lehmann HP, et al. Chronic abdominal pain in children: a Technical Report of the American Academy of Pediatrics and the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr 2005;40:249-61.
6. Rasquin A, Di Lorenzo C, Forbes D, et al. Childhood functional gastrointestinal disorders: child/adolescent. Gastroenterology 2006;130:1527-37.
7. CrowellMD, Harris L, JonesMP, et al. New insights into the pathophysiology of irritable bowel syndrome: implications for future treatments. Curr Gastroenterol Rep 2005;7:272-9.
8. Simren M, Barbara G, Flint HJ, et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013;62:159-76.
9. Windsor JJ, Macfarlane L. Irritable bowel syndrome: the need to exclude Dientamoeba fragilis. Am J Trop Med Hyg 2005;72:501.
10. Yakoob J, Jafri W, Beg MA, et al. Irritable bowel syndrome: is it associated with genotypes of Blastocystis hominis. Parasitol Res 2010;106:1033-8.
11. Barratt JL, Harkness J, Marriott D, et al. A review of Dientamoeba fragilis carriage in humans: several reasons why this organism should be considered in the diagnosis of gastrointestinal illness. Gut Microbes 2011;2:3-12.
12. Engsbro AL, Stensvold CR, Nielsen HV, et al. Treatment of Dientamoeba fragilis in patients with irritable bowel syndrome. Am J Trop Med Hyg 2012;87:1046-52.
13. Borody TJ, Warren EF, Wettstein A, et al. Eradication of Dientamoeba fragilis can resolve IBS-like symptoms. J Gastroenterol Hepatol 2002;17(Suppl.):A103.
14. Johnson EH, Windsor JJ, Clark CG. Emerging from obscurity: biological, clinical, and diagnostic aspects of Dientamoeba fragilis. Clin Microbiol Rev 2004;17:553-70.
15. Stark D, Beebe N, Marriott D, et al. Prospective study of the prevalence, genotyping, and clinical relevance of Dientamoeba fragilis infections in an Australian population. J Clin Microbiol 2005;43:2718-23.
16. Stark DJ, Beebe N, Marriott D, et al. Dientamoebiasis: clinical importance and recent advances. Trends Parasitol 2006;22:92-6.
17. Yang J, Scholten T. Dientamoeba fragilis: a review with notes on its epidemiology, pathogenicity, mode of transmission, and diagnosis. Am J Trop Med Hyg 1977;26:16-22.
18. de Wit MA, Koopmans MP, Kortbeek LM, et al. Etiology of gastroenteritis in sentinel general practices in the netherlands. Clin Infect Dis 2001;33:280-8.
19. Stark D, Barratt J, Roberts T, et al. A review of the clinical presentation of dientamoebiasis. Am J Trop Med Hyg 2010;82:614-19.
20. Lagace-Wiens PR, VanCaeseele PG, Koschik C. Dientamoeba fragilis: an emerging role in intestinal disease. CMAJ 2006;175:468-9.
21. Norberg A, Nord CE, Evengard B. Dientamoeba fragilis-a protozoal infection which may cause severe bowel distress. Clin Microbiol Infect 2003;9:65-8.
22. Girginkardesler N, Coskun S, Cuneyt Balcioglu I, et al. Dientamoeba fragilis, a neglected cause of diarrhea, successfully treated with secnidazole. Clin Microbiol Infect 2003;9:110-13.
23. Roser D, Simonsen J, Nielsen HV, et al. Dientamoeba fragilis in Denmark: epidemiological experience derived from four years of routine real-time PCR. Eur J Clin Microbiol Infect Dis 2013;32:1303-10.
24. Schure JM, de Vries M, Weel JF, et al. Symptoms and treatment of Dientamoeba fragilis infection in children, a retrospective study. Pediatr Infect Dis J 2013;32: e148-50.
25. Banik GR, Barratt JL, Marriott D. A case-controlled study of Dientamoeba fragilis infections in children. Parasitology 2011;27:1-5.
26. Stumpel OFB, Tolboom JJM, Warris A, et al. Dientamoeba fragilis, vooral bij kinderen pathogeen? Tijdschrift voor infectieziekten 2006;1:155-9.
27. Jepps MW, Dobell C. Dientamoeba fragilis n.g., n. sp.: a new intestinal amoeba from man. Parasitology 1918;10:352-67.
28. Dickinson EC, Cohen MA, Schlenker MK. Dientamoeba fragilis: a significant pathogen. Am J Emerg Med 2002;20:62-3.
29. Spencer MJ, Garcia LS, Chapin MR. Dientamoeba fragilis. An intestinal pathogen in children? Am J Dis Child 1979;133:390-3.
30. Preiss U, Ockert G, Broemme S, et al. On the clinical importance of Dientamoeba fragilis infections in childhood. J Hyg Epidemiol Microbiol Immunol 1991;35:27-34.
31. Bosman DK, Benninga MA, van de Berg P, et al. Dientamoeba fragilis: possibly an important cause of persistent abdominal pain in children. Ned Tijdschr Geneeskd 2004;148:575-9.
32. Vandenberg O, Peek R, Souayah H, et al. Clinical and microbiological features of dientamoebiasis in patients suspected of suffering from a parasitic gastrointestinal illness: a comparison of Dientamoeba fragilis and Giardia lamblia infections. Int J Infect Dis 2006;10:255-61.
33. Peek R, Reedeker FR, van Gool T. Direct amplification and genotyping of Dientamoeba fragilis from human stool specimens. J Clin Microbiol 2004;42:631-5.
34. Stark D, Barratt J, Roberts T, et al. Comparison of microscopy, two xenic culture techniques, conventional and real-time PCR for the detection of Dientamoeba fragilis in clinical stool samples. Eur J Clin Microbiol Infect Dis 2010;29:411-16.
35. Chen TL, Chan CC, Chen HP, et al. Clinical characteristics and endoscopic findingsassociated with Blastocystis hominis in healthy adults. Am J Trop Med Hyg 2003;69:213-16.
36. Leder K, Hellard ME, Sinclair MI, et al. No correlation between clinical symptoms and Blastocystis hominis in immunocompetent individuals. J Gastroenterol Hepatol 2005;20:1390-4.
37. Keystone JS, Yang J, Grisdale D, et al. Intestinal parasites in metropolitan Toronto day-care centres. Can Med Assoc J 1984;131:733-5.